Cme (CME) Share-based Compensation (2010 - 2026)

Cme (CME) has reported Share-based Compensation for 17 consecutive years, with $24.6 million the latest figure, recorded in Q2 2026.

• Quarterly Share-based Compensation rose 18.84% year-over-year to $24.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $99.5 million (up 11.42% YoY) and the FY2025 annual result came in at $94.8 million, up 5.92% from the prior year.
• Share-based Compensation advanced to $24.6 million in Q2 2026 per CME's latest filing, from $22.0 million in the prior quarter.
• Over the last five years, Share-based Compensation for CME reached as high as $28.9 million in Q4 2025 and fell as low as $18.8 million in Q2 2024.
• A 5-year average of $22.1 million and a median of $21.0 million in 2025 frame the typical range for Share-based Compensation.
• Annual changes were most pronounced in 2022 — Share-based Compensation jumped 37.1% — and 2025, when it fell 9.01%.
• Year by year, Share-based Compensation stood at $25.5 million in 2022, then declined by 4.71% to $24.3 million in 2023, then climbed by 11.52% to $27.1 million in 2024, then grew by 6.64% to $28.9 million in 2025, then decreased by 14.88% to $24.6 million in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $24.6 million, $22.0 million, and $28.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.